NEWSNovember 7, 2018
On OrthoMedex’s 3rd year anniversary, it is pleased to announce the issuance of its 3rd USPTO Patent # 10,117,973, entitled: Methods of Using Water-Soluble Inorganic Compounds for Implants. Read more September 9, 2018
OrthoMedex LLC is pleased to announce its successful completion of Connecticut’s first state sponsored Bioscience Accelerator – ABCT. Read more August 20, 2018
OrthoMedex is pleased to announce that its international research collaboration with the Medical Valley was highlighted in the GTAI journal – MARKETS. Read more February 2, 2018
|
OrthoMedex LLC is committed to the commercialization of proprietary orthopedic implants and surgical devices that leverage the antimicrobial and osteostimulative attributes of bioactive glass, in order to address the unmet infection control and implant fixation needs of the orthopedic surgeon.
For further information please contact: Jim Walls Founder & CEO OrthoMedex LLC Managing Director OrthoMedex GmbH jim.walls@orthomedex.com +1.203.393.1387 |